Literature DB >> 1716475

Mapping of autoantigenic epitopes on recombinant thyroid peroxidase fragments using the polymerase chain reaction.

J P Banga1, P S Barnett, D L Ewins, M J Page, A M McGregor.   

Abstract

Cloned cDNA templates of thyroid peroxidase (TPO) have been used in conjunction with the polymerase chain reaction (PCR) to express selected segments of the thyroid microsomal/peroxidase antigen (TMA/TPO) as recombinant protein in E. coli. Six small, different recombinant fragments averaging 120 amino acid residues and one large fragment (269 amino acids) of TPO which together encompass 80% of the extracellular region of the molecule have been produced and autoantibody (aAb) binding sites analysed by immunoblotting. A minimum of six independent, sequential antigenic determinants have been localized on the recombinant proteins and these map to the amino terminal, the central core region and the carboxyl terminal of the TPO molecule. More accurately, the six antigenic sites reside on overlapping recombinant TPO preparations termed R1a + R1b (residues 1 to 160) R1c (residues 145 to 250), R2b (residues 457 to 589), R3a (residues 577-677), R3b (residues 657-767) and R3c (residues 737-845). The large fragment of TPO termed R3 (residues 577-845) encompassing R3a, R3b and R3c also reacts with the aAbs. Different sera from patients with autoimmune thyroid disease contain antibodies to TMA/TPO which differ in their fine specificity. The use of recombinant molecular biological techniques together with PCR to prepare small segments of a large autoantigen as recombinant protein will now allow studies to progress on autoepitope mapping of the precise amino acid sequences of the TPO molecule with the use of synthetic peptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1716475     DOI: 10.3109/08916939008998418

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  6 in total

1.  Antigen-specific T cell recognition of affinity-purified and recombinant thyroid peroxidase in autoimmune thyroid disease.

Authors:  D L Ewins; P S Barnett; S Ratanachaiyavong; C Sharrock; J Lanchbury; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

2.  Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.

Authors:  G Carayanniotis; G C Huang; L B Nicholson; T Scott; P Allain; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

3.  Rarity of autoantibodies to a major autoantigen, thyroid peroxidase, that interact with denatured antigen or with epitopes outside the immunodominant region.

Authors:  J Guo; Y Wang; J C Jaume; B Rapoport; S M McLachlan
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  T cell responses to synthetic thyroid peroxidase peptides in autoimmune thyroid disease.

Authors:  N Tandon; M Freeman; A P Weetman
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

5.  Autoantigen recognition by thyroid-infiltrating T cells in Graves disease.

Authors:  C M Dayan; M Londei; A E Corcoran; B Grubeck-Loebenstein; R F James; B Rapoport; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 6.  Thyroid Autoantibodies Display both "Original Antigenic Sin" and Epitope Spreading.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.